By Steven Ertelt | Lifesite News | Mar. 6, 2012
Pepsi is back in the news this week and is coming under criticism from pro-life advocates because it has been contracting with a research firm that uses fetal cells from babies victimized by abortions to test and produce artificial flavor enhancers.
As LifeNews reported yesterday, the Obama administration is set to face more criticism because an agency has declared that Pepsi’s use of the company and its controversial flavor testing process constitutes “ordinary business.” In a decision delivered February 28, the Security and Exchange Commission ruled that PepsiCo’s use of aborted fetal remains in their research and development agreement with Senomyx to produce flavor enhancers falls under “ordinary business operations.”
However, Pepsi is not the only company that is making products that rely on cells from babies killed in abortions.
As pro-life blogger Susan Michelle notes, the full 36-page document submitted by PepsiCo attorneys in January 2012 to respond to a shareholder resolution from PepsiCo shareholders upset by Pepsi’s reliance on Senomyx shows other companies are problematic as well.We obtained the document via PepsiCo’s website but have uploaded it here for you to see if you’d like to review the entire document. If you want to cut to the chase, search FETAL and it will take you to the details.
The memo is from Office of Chief Counsel, Division of Corporation Finance, Securities and Exchange Commission and regarding “PepsiCo, Inc Shareholder Proposal of Sarah Giltner, Exchange Act of 1934-Rule 14a-8.”
You’ll note the term ordinary business, widely cites in pro-life news reports today, is used in context of other companies doing likewise, such as Merck, a pharmaceutical company that manufactures many controversial vaccines that are created with cell lines from aborted fetuses.
The document names Pfizer Inc and Merck & Co as two companies that have used or studied using fetal tissue from elective abortions to create their products. As the Pepsi document notes: We obtained the document via PepsiCo’s website but have uploaded it here for you to see if you’d like to review the entire document. If you want to cut to the chase, search FETAL and it will take you to the details.
The memo is from Office of Chief Counsel, Division of Corporation Finance, Securities and Exchange Commission and regarding “PepsiCo, Inc Shareholder Proposal of Sarah Giltner, Exchange Act of 1934-Rule 14a-8.”
You’ll note the term ordinary business, widely cites in pro-life news reports today, is used in context of other companies doing likewise, such as Merck, a pharmaceutical company that manufactures many controversial vaccines that are created with cell lines from aborted fetuses.
The document names Pfizer Inc and Merck & Co as two companies that have used or studied using fetal tissue from elective abortions to create their products. As the Pepsi document notes: